---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Karolinska Institutet

🌎 ki.se

Karolinska Institutet is one of Europe's largest medical universities, known for its extensive range of medical education and significant contribution to medical academic research. KI Innovations AB, a subsidiary, focuses on transforming research innovations into commercial products and services to create societal value.

---

Karolinska Institutet - Latest News and Updates

• Karolinska Institutet has launched a new initiative as announced on November 20, 2024.
• Karolinska Institutet is collaborating with the University of Oviedo and the University of Nicosia to offer an Erasmus Mundus Master's in Public Health in Disasters.
• Researchers at Karolinska Institutet discovered a molecule that aids gut healing and removes tumor growth in colorectal cancer, potentially leading to new treatments for IBD and cancer.
• Scientists from Karolinska Institutet, Emory University, and the University of Oxford miniaturized a TR-FRET assay to study the SYK and FCER1G interaction in a 1536-well ultra-high throughput screening format.
• Karolinska Institutet is advancing neuroscience research by exploring self-supervised learning methods and developing AI solutions to enhance brain imaging techniques.

• Karolinska Institutet is hosting a networking event at Biomedicum on November 26 to explore their core facilities and connect researchers.
• Dr. J-Matthias Löhr from Karolinska Institutet led new research on using liquid biopsy to diagnose pancreatic incidentaloma, potentially indicating early-stage pancreatic cancer.
• Karolinska Institutet researchers have developed a new method to read cellular information faster and more accurately.
• Karolinska Institutet conducted a nationwide study on pancreatic cancer risk following benign gallbladder disease.
• Karolinska Institutet researchers identified ARNTL as a regulator of smooth muscle cells, enhancing risk stratification for cardiovascular diseases.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.